49 related articles for article (PubMed ID: 21711077)
21. Innovative chemotherapies for stage III colon cancer: a cost-effectiveness study.
Koperna T; Semmler D
Hepatogastroenterology; 2003; 50(54):1903-9. PubMed ID: 14696430
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data.
Hess LM; Michael D; Mytelka DS; Beyrer J; Liepa AM; Nicol S
Gastric Cancer; 2016 Apr; 19(2):607-615. PubMed ID: 25792290
[TBL] [Abstract][Full Text] [Related]
23. Cost differential by site of service for cancer patients receiving chemotherapy.
Hayes J; Hoverman RJ; Brow ME; Dilbeck DC; Verrilli DK; Garey J; Espirito JL; Cardona J; Beveridge R
Am J Manag Care; 2015 Mar; 21(3):e189-96. PubMed ID: 26014306
[TBL] [Abstract][Full Text] [Related]
24. Associations between clinical pathway concordance, cost, and survival outcomes for stage II colon cancer: a population-based study.
Milroy S; Wong J; Eberg M; Ieraci L; Forster K; Holloway CMB; Sutherland JM
Int J Qual Health Care; 2023 Apr; 35(2):. PubMed ID: 36961746
[TBL] [Abstract][Full Text] [Related]
25. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract][Full Text] [Related]
26. A visual approach of care pathways from the French nationwide SNDS database - from population to individual records: the ePEPS toolbox.
Happe A; Drezen E
Fundam Clin Pharmacol; 2018 Feb; 32(1):81-84. PubMed ID: 28921707
[TBL] [Abstract][Full Text] [Related]
27. N.J. hospitals team to build pathways database open to competitors.
Schuckman P
Healthc Syst Strategy Rep; 1995 Sep; 12(20):11. PubMed ID: 10151785
[No Abstract] [Full Text] [Related]
28. Unlocking datasets.
Edouard L; Rawson NS
Lancet; 1994 Jan; 343(8889):118. PubMed ID: 7903750
[No Abstract] [Full Text] [Related]
29. Clinical pathways: reducing costs and improving quality across a network.
Neubauer M
Am J Manag Care; 2020 Feb; 26(2 Spec No.):SP60-SP61. PubMed ID: 32078282
[No Abstract] [Full Text] [Related]
30. The bird's-eye view: A data-driven approach to understanding patient journeys from claims data.
Bobroske K; Larish C; Cattrell A; Bjarnadóttir MV; Huan L
J Am Med Inform Assoc; 2020 Jul; 27(7):1037-1045. PubMed ID: 32521006
[TBL] [Abstract][Full Text] [Related]
31. Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.
Feinberg BA; Lang J; Grzegorczyk J; Stark D; Rybarczyk T; Leyden T; Cooper J; Ruane T; Milligan S; Stella P; Scott JA
J Oncol Pract; 2012 May; 8(3 Suppl):e38s-43s. PubMed ID: 22942833
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy for colon cancer--analysis of treatment costs from the perspective of statutory sickness funds.
Görner M; Riemer-Hommel P
Z Gastroenterol; 2008 Jul; 46(7):681-8. PubMed ID: 18618379
[TBL] [Abstract][Full Text] [Related]
33. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
McNaughton-Collins M; Walker-Corkery E; Barry MJ
J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
[TBL] [Abstract][Full Text] [Related]
35. Measuring costs: administrative claims data, clinical trials, and beyond.
Etzioni R; Riley GF; Ramsey SD; Brown M
Med Care; 2002 Jun; 40(6 Suppl):III63-72. PubMed ID: 12064760
[TBL] [Abstract][Full Text] [Related]
36. Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases.
Hoverman JR; Cartwright TH; Patt DA; Espirito JL; Clayton MP; Garey JS; Kopp TJ; Kolodziej M; Neubauer MA; Fitch K; Pyenson B; Beveridge RA
Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP45-52. PubMed ID: 21711077
[TBL] [Abstract][Full Text] [Related]
37. Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.
Hoverman JR; Cartwright TH; Patt DA; Espirito JL; Clayton MP; Garey JS; Kopp TJ; Kolodziej M; Neubauer MA; Fitch K; Pyenson B; Beveridge RA
J Oncol Pract; 2011 May; 7(3 Suppl):52s-9s. PubMed ID: 21886520
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
